HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3,3'- (1H,3'H- 5,5'- bibenzo(d)imidazole- 2,2'- diyl)dianiline

modulates the DNA damage response; structure in first source

Also Known As:

DDRI-18

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Aniline Compounds: 46
    - 3,3'-(1H,3'H-5,5'-bibenzo(d)imidazole-2,2'-diyl)dianiline: 1
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzimidazoles: 245
      - 3,3'-(1H,3'H-5,5'-bibenzo(d)imidazole-2,2'-diyl)dianiline: 1

Related Diseases

1.	Ovarian Neoplasms (Ovarian Cancer) 09/28/2023 - "DNA Double-Strand Break Repair Inhibitors: YU238259, A12B4C3 and DDRI-18 Overcome the Cisplatin Resistance in Human Ovarian Cancer Cells, but Not under Hypoxia Conditions."
2.	Hypoxia (Hypoxemia) 09/28/2023 - "DNA Double-Strand Break Repair Inhibitors: YU238259, A12B4C3 and DDRI-18 Overcome the Cisplatin Resistance in Human Ovarian Cancer Cells, but Not under Hypoxia Conditions."

Related Drugs and Biologics

1.	DNA (Deoxyribonucleic Acid)
2.	Cisplatin (Platino)
3.	2- (1- hydroxyundecyl)- 1- (4- nitrophenylamino)- 6- phenyl- 6,7a- dihydro- 1H- pyrrolo(3,4- b)pyridine- 5,7(2H,4aH)- dione
4.	YU238259